Musculoskeletal manifestations in children with Behcet's syndrome: data from the AIDA Network Behcet's Syndrome Registry
dc.contributor.author | Gaggiano, C | |
dc.contributor.author | Maselli, A | |
dc.contributor.author | Sfikakis, PP | |
dc.contributor.author | Laskari, K | |
dc.contributor.author | Ragab, G | |
dc.contributor.author | Hegazy, MT | |
dc.contributor.author | Laymouna, AH | |
dc.contributor.author | Lopalco, G | |
dc.contributor.author | Almaghlouth, IA | |
dc.contributor.author | Asfina, KN | |
dc.contributor.author | Alahmed, O | |
dc.contributor.author | Mayrink, HAG | |
dc.contributor.author | Antonelli, IPD | |
dc.contributor.author | Cattalini, M | |
dc.contributor.author | Piga, M | |
dc.contributor.author | Sota, J | |
dc.contributor.author | Gentileschi, S | |
dc.contributor.author | Maggio, MC | |
dc.contributor.author | Opris-Belinski, D | |
dc.contributor.author | Hatemi, G | |
dc.contributor.author | Insalaco, A | |
dc.contributor.author | Olivieri, AN | |
dc.contributor.author | Tufan, A | |
dc.contributor.author | Karadeniz, H | |
dc.contributor.author | Kardas, RC | |
dc.contributor.author | La Torre, F | |
dc.contributor.author | Cardinale, F | |
dc.contributor.author | Marino, A | |
dc.contributor.author | Guerriero, S | |
dc.contributor.author | Ruscitti, P | |
dc.contributor.author | Tarsia, M | |
dc.contributor.author | Vitale, A | |
dc.contributor.author | Caggiano, V | |
dc.contributor.author | Telesca, S | |
dc.contributor.author | Iannone, F | |
dc.contributor.author | Parretti, V | |
dc.contributor.author | Frassi, M | |
dc.contributor.author | Aragona, E | |
dc.contributor.author | Ciccia, F | |
dc.contributor.author | Wiesik-Szewczyk, E | |
dc.contributor.author | Ionescu, R | |
dc.contributor.author | Sahin, A | |
dc.contributor.author | Akkoç, N | |
dc.contributor.author | Hinojosa-Azaola, A | |
dc.contributor.author | Tharwat, S | |
dc.contributor.author | Hernández-Rodríguez, J | |
dc.contributor.author | Espinosa, G | |
dc.contributor.author | Conti, G | |
dc.contributor.author | Del Giudice, E | |
dc.contributor.author | Govoni, M | |
dc.contributor.author | Emmi, G | |
dc.contributor.author | Fabiani, C | |
dc.contributor.author | Balistreri, A | |
dc.contributor.author | Frediani, B | |
dc.contributor.author | Rigante, D | |
dc.contributor.author | Cantarini, L | |
dc.date.accessioned | 2024-07-18T12:08:44Z | |
dc.date.available | 2024-07-18T12:08:44Z | |
dc.description.abstract | This study aims to describe musculoskeletal manifestations (MSM) in children with Behcet's syndrome (BS), their association with other disease manifestations, response to therapy, and long-term prognosis. Data were retrieved from the AIDA Network Behcet's Syndrome Registry. Out of a total of 141 patients with juvenile BS, 37 had MSM at disease onset (26.2%). The median age at onset was 10.0 years (IQR 7.7). The median follow-up duration was 21.8 years (IQR 23.3). Recurrent oral (100%) and genital ulcers (67.6%) and pseudofolliculitis (56.8%) were the most common symptoms associated with MSM. At disease onset, 31 subjects had arthritis (83.8%), 33 arthralgia (89.2%), and 14 myalgia (37.8%). Arthritis was monoarticular in 9/31 cases (29%), oligoarticular in 10 (32.3%), polyarticular in 5 (16.1%), axial in 7 (22.6%). Over time, arthritis became chronic-recurrent in 67.7% of cases and 7/31 patients had joint erosions (22.6%). The median Behcet's Syndrome Overall Damage Index was 0 (range 0-4). Colchicine was inefficacious for MSM in 4/14 cases (28.6%), independently from the type of MSM (p = 0.46) or the concomitant therapy (p = 0.30 for cDMARDs, p = 1.00 for glucocorticoids); cDMARDs and bDMARDs were inefficacious for MSM in 6/19 (31.4%) and 5/12 (41.7%) cases. The presence of myalgia was associated with bDMARDs inefficacy (p = 0.014). To conclude, MSM in children with BS are frequently associated with recurrent ulcers and pseudofolliculitis. Arthritis is mostly mono- or oligoarticular, but sacroiliitis is not unusual. Prognosis of this subset of BS is overall favorable, though the presence of myalgia negatively affects response to biologic therapies. ClinicalTrials.gov Identifier: NCT05200715 (registered on December 18, 2021). | |
dc.identifier.issn | 1828-0447 | |
dc.identifier.other | 1970-9366 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/11055 | |
dc.language.iso | English | |
dc.publisher | SPRINGER-VERLAG ITALIA SRL | |
dc.subject | COMPUTED-TOMOGRAPHY | |
dc.subject | DISEASE | |
dc.subject | SACROILIITIS | |
dc.subject | ARTHRITIS | |
dc.subject | CRITERIA | |
dc.subject | ACNE | |
dc.title | Musculoskeletal manifestations in children with Behcet's syndrome: data from the AIDA Network Behcet's Syndrome Registry | |
dc.type | Article |